Clinical Trial Update: Clinical Performance Evaluation of DxN HBV Assay

View source ↗

Summary

A terminated clinical performance evaluation study of the DxN HBV Assay for Hepatitis B, assessing its diagnostic performance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DxN HBV Assay

Snippet

Sponsor: Beckman Coulter, Inc. | Conditions: Hepatitis B | Status: TERMINATED